Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Ribelles

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 22, 2005
Looking for the right drug for the right patient: a tale of old drugs and new pathwaysEmilio Alba, Nuria Ribelles
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 21, 2010
Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question?Alfonso Sánchez-Muñoz, Nuria Ribelles, Emilio Alba
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2010
Insidious mastalgia hiding a desmoid tumour of the breastBella Pajares, Irene Galera, Nuria Ribelles, et al.
Cancer Treatment Reviews|October 12, 2013
The seed and soil hypothesis revisited: current state of knowledge of inherited genes on prognosis in breast cancerNuria Ribelles, Angela Santonja, Bella Pajares, et al.
Computer Methods and Programs in Biomedicine|October 1, 2016
Supervised discretization can discover risk groups in cancer survival analysisIván Gómez, Nuria Ribelles, Leonardo Franco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practiceAlfonso Sánchez-Muñoz, Nuria Ribelles, Antonia Márquez, et al.
Acta Oncologica (Stockholm, Sweden)|February 25, 2009
Response to paclitaxel in a radiotherapy-induced breast angiosarcomaElisabeth Perez-Ruiz, Nuria Ribelles, Alfonso Sanchez-Muñoz, et al.
Journal of Biomedical Informatics|February 22, 2023
Explainable clinical coding with in-domain adapted transformersGuillermo López-García, José M Jerez, Nuria Ribelles, et al.
Cancers|July 26, 2020
Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular PredictorsMaría Rosario Chica-Parrado, Ana Godoy-Ortiz, Begoña Jiménez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2012
Tyrosine kinase inhibitors and drug interactions: a review with practical recommendationsBella Pajares, Esperanza Torres, José Manuel Trigo, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 22, 2005
Looking for the right drug for the right patient: a tale of old drugs and new pathwaysEmilio Alba, Nuria Ribelles
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 21, 2010
Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question?Alfonso Sánchez-Muñoz, Nuria Ribelles, Emilio Alba
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2010
Insidious mastalgia hiding a desmoid tumour of the breastBella Pajares, Irene Galera, Nuria Ribelles, et al.
Cancer Treatment Reviews|October 12, 2013
The seed and soil hypothesis revisited: current state of knowledge of inherited genes on prognosis in breast cancerNuria Ribelles, Angela Santonja, Bella Pajares, et al.
Computer Methods and Programs in Biomedicine|October 1, 2016
Supervised discretization can discover risk groups in cancer survival analysisIván Gómez, Nuria Ribelles, Leonardo Franco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practiceAlfonso Sánchez-Muñoz, Nuria Ribelles, Antonia Márquez, et al.
Acta Oncologica (Stockholm, Sweden)|February 25, 2009
Response to paclitaxel in a radiotherapy-induced breast angiosarcomaElisabeth Perez-Ruiz, Nuria Ribelles, Alfonso Sanchez-Muñoz, et al.
Journal of Biomedical Informatics|February 22, 2023
Explainable clinical coding with in-domain adapted transformersGuillermo López-García, José M Jerez, Nuria Ribelles, et al.
Cancers|July 26, 2020
Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular PredictorsMaría Rosario Chica-Parrado, Ana Godoy-Ortiz, Begoña Jiménez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2012
Tyrosine kinase inhibitors and drug interactions: a review with practical recommendationsBella Pajares, Esperanza Torres, José Manuel Trigo, et al.
Pageof 6